WXXWY
WUXI BIOLOGICS UNSP/ADRstockOTCADR
wuxi biologics provides an open-access, integrated technology platform for biologics drug development. we are the only true service platform in the world offering end-to-end solutions to empower anyone to discover, develop and manufacture biologics from concept to commercial manufacturing. our single-source approach to biologics development saves our clients critical time and money. see below how our experience, capacities and quality make us a world leading (cdmo). experience wuxi biologics' leadership team consists of industry experts with 15-20 years of experience in biological drug development in the u.s./eu. while at wuxi this team has contributed to 1 bla and 66 worldwide inds in just 3 years! expertise wuxi biologics has over 170+ returnees from large pharma and small biotechs in the u.s./eu. these scientists cover all facets of drug development from discovery to manufacture of final drug product. capacity and capabilities we have strong technical capabilities and an open-access
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 13.66 | 2026-09-28 | +2.12% | -5.263 |
| 1M | 12.55 | 2026-09-04 | +11.15% | 1.775 |
| 3M | 9.62 | 2026-07-06 | +45.01% | 1.105 |
| 6M | 9.05 | 2026-04-06 | +54.14% | 0.653 |
| 1Y | 10.85 | 2025-10-03 | +28.57% | 1.095 |
| 2Y | 5.45 | 2024-10-04 | +155.96% | — |
| 5Y | 29.64 | 2021-10-04 | -52.94% | 0.538 |
WUXI BIOLOGICS UNSP/ADR (OTC:WXXWY) stock price today is $13.95, and today's volume is 26,403. WXXWY is down 2.448% today. The 30 day average volume is 76,168. WXXWY market cap is $28.97B with 2.08B shares outstanding.